GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Northland Biotech Co Ltd (BJSE:430047) » Definitions » Cyclically Adjusted Price-to-FCF

Beijing Northland Biotech Co (BJSE:430047) Cyclically Adjusted Price-to-FCF : (As of Jun. 19, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Northland Biotech Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Beijing Northland Biotech Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Beijing Northland Biotech Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Northland Biotech Co Cyclically Adjusted Price-to-FCF Chart

Beijing Northland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Beijing Northland Biotech Co Quarterly Data
Mar19 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Beijing Northland Biotech Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Beijing Northland Biotech Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Northland Biotech Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Northland Biotech Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Beijing Northland Biotech Co's Cyclically Adjusted Price-to-FCF falls into.



Beijing Northland Biotech Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Beijing Northland Biotech Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Beijing Northland Biotech Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.097/115.2271*115.2271
=-0.097

Current CPI (Mar. 2024) = 115.2271.

Beijing Northland Biotech Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200906 0.000 83.615 0.000
200912 0.000 85.386 0.000
201006 0.000 85.886 0.000
201012 0.000 89.289 0.000
201106 0.000 91.612 0.000
201112 0.000 92.885 0.000
201206 0.000 93.495 0.000
201212 0.000 95.237 0.000
201306 0.000 95.984 0.000
201312 0.000 97.624 0.000
201406 0.000 98.200 0.000
201412 0.000 99.000 0.000
201506 0.000 99.500 0.000
201512 0.000 100.600 0.000
201606 0.000 101.400 0.000
201612 0.000 102.600 0.000
201706 0.000 103.100 0.000
201712 0.000 104.500 0.000
201806 0.000 104.900 0.000
201812 0.000 106.500 0.000
201903 -0.056 107.700 -0.060
201906 -0.048 107.700 -0.051
201912 0.000 111.200 0.000
202003 0.010 112.300 0.010
202006 0.029 110.400 0.030
202009 -0.035 111.700 -0.036
202012 -0.059 111.500 -0.061
202103 -0.031 112.662 -0.032
202106 -0.020 111.769 -0.021
202109 -0.037 112.215 -0.038
202112 -0.042 113.108 -0.043
202203 0.001 114.335 0.001
202206 -0.083 114.558 -0.083
202209 -0.008 115.339 -0.008
202212 -0.103 115.116 -0.103
202303 -0.029 115.116 -0.029
202306 -0.218 114.558 -0.219
202309 -0.060 115.339 -0.060
202312 -0.058 114.781 -0.058
202403 -0.097 115.227 -0.097

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beijing Northland Biotech Co  (BJSE:430047) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Beijing Northland Biotech Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Beijing Northland Biotech Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Northland Biotech Co (BJSE:430047) Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Shangdi Kaikai Road, A406, Zhongguancun Biomedical Park, Haidian District, Beijing, CHN, 100085
Beijing Northland Biotech Co Ltd is a biopharmaceutical company specializing in the research and development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs.

Beijing Northland Biotech Co (BJSE:430047) Headlines

No Headlines